Friday, April 13, 2018
News Recap:
Canada:
Initiative aims to treat Hepatitis C in Alberta patients who also have HIV. A long-term effort to eliminate Hepatitis C as a public health threat is underway in Alberta, where a new program aims to provide medications to one particularly vulnerable group of patients. NOTE: In Alberta, coverage has been expanded as of April 1 to include all patients with hepatitis C. Previously, coverage was provided only to...
71 million people stand to benefit from reduced price treatment for virus which can lead to liver cirrhosis, cancer and death.
An affordable hepatitis C treatment has been shown to be safe and effective, with very high cure rates for patients including hard-to-treat cases, in interim clinical trial results that offer hope to the 71 million people living with the disease worldwide.
The treatment is expected to cost $300 for 12 weeks, or $3.50 per day, i...
A hepatitis C treatment that costs less than $300 – a fraction of the $80,000-plus price charged by major drugmakers – has been successfully tested in Egypt and is expected to be available in the next one to two years.
The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit organisation, has teamed up with the Egyptian drugmaker Pharco Pharmaceuticals to bring a combination treatment of two hepatitis C tablets, ravidasvir and sofosbuvir, to...
